Hillenbrand — Q3 2025 Earnings Presentation
25 slides from Hillenbrand's earnings presentation, Aug 12, 2025
Slide 1: Third Quarter FY 2025 Earnings Call Presentation
Third Quarter FY 2025 Earnings Call Presentation August 12, 2025
Slide 2: Hillenbrand Call Participants
Hillenbrand Call Participants Kim Ryan Megan Walke Trent Schwartz President & CEO VP & Interim CFO Executive Director, IR 2
Slide 3: Disclosure Regarding Forward-Looking Statements
Disclosure Regarding Forward-Looking Statements Throughout this earnings presentation, we make a number of “forward-looking statements,” including statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as a
Slide 4: Executing FY25 Initiatives
Executing FY25 Initiatives SIMPLIFY ✓ Divested majority stake in Milacron for approximately $265 million in net proceeds PORTFOLIO ✓ Sold minority interest in TerraSource for approximately $115 million in net proceeds REDUCE ✓ Used proceeds from Milacron and TerraSource transactions to reduce DEBT t
Slide 5: Transformation Update: Food, Health, and Nutrition
Transformation Update: Food, Health, and Nutrition (FHN) 2022 to 2023 TODAY FHN Acquisitions Hillenbrand Revenues by End Market FY22 FY25E ✓ GDP+, Secular Achieved targeted $30 million Growth of run-rate cost synergies 3% GDP+, Secular Secular 4% Growth Decline 7% 21% 28% 4% 37% FPM 30% Food and 31%
Slide 6: Q3 Overview
Q3 Overview Q3 2025 Key Metrics1,2 • Achieved annual run-rate cost synergy commitment of $30 million from Linxis and FPM acquisitions ahead of schedule, positioning Hillenbrand for strong adj. EBITDA margin performance and value creation as $663M -10% $599M demand normalizes Pro Forma Net Revenue •
Slide 7: Tariff Response Strategy
Tariff Response Strategy Near-Term Actions Mid- to Longer-Term Actions In-Region For-Region (IRFR) Continued IRFR Initiatives Utilize global manufacturing footprint with regionalized production Manufacturing capability transfer between regions Surcharge Pricing Strategic Sourcing Transition to alter
Slide 8: Q3 Consolidated Performance
Q3 Consolidated Performance1,2 Pro Forma Net Revenue1,2 Pro Forma Adj. EBITDA1,2 Adj. EPS2 Operating Cash Flow -10% -28% -40% -$47M $46 $0.85 $663 $117 $599 $84 $0.51 $(2) Q3 2024 Q3 2025 Q3 2024 Q3 2025 Q3 2024 Q3 2025 Q3 2024 Q3 2025 Performance Highlights1,2 Business Update1,2 • Net revenue of $5
Slide 9: Segment Performance: Advanced Process Solutions
Segment Performance: Advanced Process Solutions Net Revenue Adj. EBITDA1 Adj. EBITDA Margin1 -11% -27% -340 bps $569 $507 $109 19.2% $80 15.8% Q3 2024 Q3 2025 Q3 2024 Q3 2025 Q3 2024 Q3 2025 Performance Highlights1 Business Update • Net revenue of $507 million decreased 11%, primarily driven by lowe
Slide 10: Segment Performance: Molding Technology Solutions
Segment Performance: Molding Technology Solutions1,2 Pro Forma Net Revenue1,2 Pro Forma Adj. EBITDA1,2 Pro Forma Adj. EBITDA Margin1,2 -2% -9% -170 bps $94 $92 $20 21.6% $18 19.9% Q3 2024 Q3 2025 Q3 2024 Q3 2025 Q3 2024 Q3 2025 Performance Highlights1 Business Update • Net revenue of $92 million dec
Slide 11: Capital Deployment / Capital Position
Capital Deployment / Capital Position Liquidity3 ($M) Debt Maturity Schedule4 ($M) Maintain Appropriate Leverage $459 $500 • Desired net leverage1 range of 1.7x – 2.7x • Top priority for cash flow is reducing leverage to return to preferred range Cash $375 $163 $350 Total Liquidity Reinvest in the B
Slide 12: FY25 Guidance – Updating Core Outlook, Maintaining Mid-Point of Adjusted EPS
FY25 Guidance – Updating Core Outlook, Maintaining Mid-Point of Adjusted EPS Updated Guidance Previous Guidance Advanced Molding Advanced Molding Hillenbrand Process Technology Hillenbrand Process Technology Solutions Solutions Solutions Solutions Net Revenue $2,595 - $2,630 $2,005 - $2,030 $590 - $
Slide 13: Q&A
Q&A HILLENBRAND 13
Slide 14: Replay Information
Replay Information • Dial-in for US and Canada: +1 (877) 407-8012 • Dial-in for International: +1 (412) 902-1013 • Conference ID: 13754423 • Date/Time: Available until midnight ET, Tuesday, August 26, 2025 • Log-on to: http://ir.hillenbrand.com 14
Slide 15: Appendix
Appendix HILLENBRAND
Slide 16: Disclosure Regarding Non-GAAP Financial Measures
Disclosure Regarding Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with United States generally accepted accounting principles (GAAP), this earnings presentation also contains non-GAAP operating performance measures. These non-GAAP financial measures are re
Slide 17: Reconciliation of Adjusted EBITDA to Consolidated Net Income (Loss)
Reconciliation of Adjusted EBITDA to Consolidated Net Income (Loss) Three Months Ended June 30, Nine Months Ended June 30, (in millions) 2025 2024 2025 2024 Adjusted EBITDA: Advanced Process Solutions $ 80.1 $ 109.2 $ 241.7 $ 306.0 Molding Technology Solutions 18.3 34.6 78.0 100.3 Corporate (14.1) (
Slide 18: Reconciliation of Income (Loss) to Adjusted Net Income & Diluted EPS
Reconciliation of Income (Loss) to Adjusted Net Income & Diluted EPS to Adjusted Diluted EPS for Continuing Operations Three Months Ended June 30, Nine Months Ended June 30, (in millions, except per share data) 2025 2024 2025 2024 Income (loss) from continuing operations $ 4.1 $ (246.9) $ (25.6) $ (
Slide 19: Reconciliation of Consolidated Net Income (Loss) to Pro Forma Adjusted EBITDA
Reconciliation of Consolidated Net Income (Loss) to Pro Forma Adjusted EBITDA Three Months Ended June 30, Nine Months Ended June 30, (in millions) 2025 2024 2025 2024 Consolidated net income (loss) $ 4.1 $ (246.9) $ (25.6) $ (219.1) Interest expense, net 21.3 32.2 69.6 92.8 Income tax expense (benef
Slide 20: Reconciliation of Reported Net Revenue to Pro Forma Net Revenue
Reconciliation of Reported Net Revenue to Pro Forma Net Revenue Three Months Ended June 30, (in millions) 2025 2024 Advanced Process Solutions net revenue $ 507.0 $ 569.4 Molding Technology Solutions net revenue 91.9 217.2 Less: Divestiture (1) - 123.6 Molding Technology Solutions pro forma net reve
Slide 21: Reconciliation of Reported Backlog to Pro Forma Backlog
Reconciliation of Reported Backlog to Pro Forma Backlog June 30, June 30, (in millions) 2025 2024 Advanced Process Solutions backlog $ 1,569.6 $ 1,735.7 Molding Technology Solutions backlog 54.6 238.5 Less: Divestiture (1) - 187.3 Molding Technology Solutions pro forma backlog 54.6 51.2 Consolidated
Slide 22: Ratio of Net Debt to Pro Forma Adjusted EBITDA
Ratio of Net Debt to Pro Forma Adjusted EBITDA for the Trailing Twelve Months Ended June 30, (in millions) 2025 Current portion of long-term debt $ 12.6 Long-term debt 1,663.6 Total debt 1,676.2 Less: Cash and cash equivalents 162.8 Net debt $ 1,513.4 Pro forma adjusted EBITDA for the trailing twelv
Slide 23: Reconciliation of Net Cash Flows
Reconciliation of Net Cash Flows Nine Months Ended June 30, (in millions) 2025 2024 Cash flows (used in) provided by: Operating activities from continuing operations $ (11.5) $ 24.8 Investing activities from continuing operations 84.4 (40.2) Financing activities from continuing operations (107.0) 13
Slide 24: Reconciliation of GAAP Weighted Average Shares Outstanding
Reconciliation of GAAP Weighted Average Shares Outstanding (Diluted) to Pro Forma Weighted Average Shares Outstanding (Diluted) Three Months Ended June 30, Nine Months Ended June 30, 2025 2024 2025 2024 GAAP weighted average shares outstanding (diluted) 70.8 70.5 70.7 70.4 Non-GAAP dilutive shares e
Slide 25: Reconciliation of GAAP Effective Tax Rate to Adjusted Effective Tax Rate
Reconciliation of GAAP Effective Tax Rate to Adjusted Effective Tax Rate Three Months Ended June 30, Nine Months Ended June 30, 2025 2024 2025 2024 GAAP effective tax rate 61.3% 4.1% (39.1%) (1.7%) Impairment - 15.5 - 36.0 Discrete impact of Milacron divestiture (29.1) - 255.4 - Unrecognized tax ben